CCIA
NTUS

Campbell & Co Investment Adviser’s Natus Medical Inc NTUS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,206
Closed -$268K – 994
2022
Q1 		$268K Buy
+10,206
New +$249K 0.07% 516
2017
Q3 		– Sell
-5,467
Closed -$204K – 482
2017
Q2 		$204K Buy
+5,467
New +$197K 0.19% 265

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Campbell & Co Investment Adviser's NTUS Position: Q2 2022 in Review

Campbell & Co Investment Adviser sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 10,206 shares — an estimated $268K sold.

Campbell & Co Investment Adviser first reported a position in NTUS in Q2 2017 and held it in 2 quarters. The position peaked at $268K in Q1 2022. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Campbell & Co Investment Adviser reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 10,206 Natus Medical Inc shares in Q2 2022, an estimated $268K.
  • Campbell & Co Investment Adviser first reported a position in Natus Medical Inc in Q2 2017 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's Natus Medical Inc position peaked at $268K in Q1 2022.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2022, filed 9 Aug 2022.